Home » Topics » BioWorld Science

BioWorld Science
RSS

Hungarian scientists patent myosin-2 ATPase activity inhibitors

Nov. 7, 2019

Chinese researchers present new p300 HAT inhibitors

Nov. 7, 2019

VTCN1 gene linked to schizophrenia in Chinese families

Nov. 7, 2019

Thomas Helledays Stiftelse foer Medicinsk Forskning divulges MTHFD2 inhibitors

Nov. 7, 2019

U.K. researchers patent BCL-6 inhibitors

Nov. 7, 2019

Bristol-Myers Squibb presents new MGAT2 inhibitors

Nov. 7, 2019

Lilly opens phase I study of LY-3435151 in advanced solid tumors

Nov. 7, 2019

Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia

Nov. 7, 2019

New phase I trial explores BI-1701963 in KRAS-mutated advanced or metastatic solid tumors

Nov. 7, 2019

Boehringer Ingelheim reports data on new SOS1-KRAS interaction inhibitors for cancer

Nov. 7, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...